| 產(chǎn)品名稱 |
5C9 |
| 商品貨號 |
B163794 |
| Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type |
hybridoma: B lymphocyte |
| Product Format |
frozen |
| Morphology |
lymphoblast |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Derivation |
Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed |
immunoglobulin; monoclonal antibody; against porcine (pig) IgM (mu heavy chain) |
| Cellular Products |
immunoglobulin; monoclonal antibody; against porcine (pig) IgM (mu heavy chain) |
| Comments |
Animals were immunized with porcine IgM. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Complete Growth Medium |
Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 92.5%; agamma horse serum, 5%; bovine calf serum, 2.5%
|
| Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 1 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype |
IgG1; kappa light chain |
| Name of Depositor |
The United States of America |
| U.S. Patent Number |
|
| References |
Paul PS, Van Deusen RA. Monoclonal antibodies to porcine immunoglobulins. US Patent 4,468,346 dated Aug 28 1984
Burke DS, et al. Japanese encephalitis virus immunoglobulin M antibodies in porcine sera. Am. J. Vet. Res. 46: 2054-2057, 1985. PubMed: 2998237
|
